These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 11034803)
1. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience. Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803 [TBL] [Abstract][Full Text] [Related]
2. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Chikhlikar PR; Ghosh N Head Neck; 2000 May; 22(3):257-64. PubMed ID: 10748449 [TBL] [Abstract][Full Text] [Related]
3. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229 [TBL] [Abstract][Full Text] [Related]
4. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
6. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence. Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061 [TBL] [Abstract][Full Text] [Related]
7. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375 [TBL] [Abstract][Full Text] [Related]
8. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related]
9. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
10. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045 [TBL] [Abstract][Full Text] [Related]
11. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097 [TBL] [Abstract][Full Text] [Related]
12. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status. Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978 [TBL] [Abstract][Full Text] [Related]
13. Survivin expression predicts early recurrence in early-stage breast cancer. Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451 [TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma. Copp HL; Chin JL; Conaway M; Theodorescu D Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580 [TBL] [Abstract][Full Text] [Related]
15. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345 [TBL] [Abstract][Full Text] [Related]
16. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers. Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473 [TBL] [Abstract][Full Text] [Related]
17. WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Płuciennik E; Kusińska R; Potemski P; Kubiak R; Kordek R; Bednarek AK Eur J Surg Oncol; 2006 Mar; 32(2):153-7. PubMed ID: 16360296 [TBL] [Abstract][Full Text] [Related]
18. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer. Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742 [TBL] [Abstract][Full Text] [Related]
20. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]